US Broker Ratings

Immunocore Holdings plc (IMCR) Stock Analysis: Significant Upside Potential with a 102% Gain on the Horizon

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector with its innovative approach to developing immunotherapies for cancer, infectious, and autoimmune diseases. With a..

ICU Medical, Inc. (ICUI) Stock Analysis: Investors Eye 20% Upside Potential Amid Healthcare Sector Dynamics

ICU Medical, Inc. (NASDAQ: ICUI) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in San Clemente,..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating Growth in Rare Diseases with Strong Revenue Momentum

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stands at the forefront of the biotechnology sector, leveraging its innovative approach to develop treatments for rare diseases. With a market..

SS Innovations International (SSII) Stock Analysis: Unpacking the 192.5% Revenue Growth in the Healthcare Robotics Sector

SS Innovations International, Inc. (OTC: SSII) is carving a niche in the burgeoning healthcare sector, specifically in medical devices, with its innovative approach to surgical robotics...

Clover Health Investments (CLOV) Stock Analysis: A Potential 64% Upside for Investors

Clover Health Investments, Corp. (NASDAQ: CLOV) is capturing the attention of investors with a compelling mix of challenges and opportunities. Operating within the dynamic healthcare sector,..

Dynavax Technologies Corporation (DVAX) Investor Outlook: A Glimpse into Its 3.23% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a prominent player in the healthcare sector, is garnering attention for its innovative approach to vaccine development. With a market capitalization..

MannKind Corporation (MNKD) Stock Analysis: Exploring a 72.55% Potential Upside in Biotech

MannKind Corporation (NASDAQ: MNKD) offers an intriguing prospect for investors searching for opportunities in the biotech sector. With a market capitalization of $1.71 billion, MannKind stands..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: A 169% Upside Potential Sparks Interest

Viking Therapeutics, Inc. (NASDAQ: VKTX) stands at a pivotal juncture in the biotech sector, capturing investor attention with a remarkable 169% potential upside, as projected by..

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a Potential 95.87% Upside in a Challenging Landscape

Teladoc Health, Inc. (NYSE: TDOC), a healthcare industry disruptor, is at a pivotal moment for investors, with a potential upside of 95.87% as analysts weigh in..

Indivior Pharmaceuticals, Inc. (INDV) Investor Outlook: Strong Buy Ratings and 38% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) is garnering significant attention in the healthcare sector, particularly among investors focused on the drug manufacturers specializing in opioid dependence treatments...

Addus HomeCare Corporation (ADUS) Stock Analysis: Promising 19.87% Upside with Strong Buy Ratings

Addus HomeCare Corporation (NASDAQ: ADUS), a notable player in the healthcare sector, operates within the medical care facilities industry and has been capturing investor attention with..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 45% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Progyny, Inc. (NASDAQ: PGNY) presents an intriguing prospect. Headquartered in New York, Progyny specializes in fertility and family-building..

Alvotech (ALVO) Stock Analysis: Exploring a 425% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) is making waves in the healthcare sector, primarily through its innovative approach to biosimilar medicines. Operating from Luxembourg, Alvotech is carving a niche..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 57% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector, pioneering advancements in gene editing with its cutting-edge CRISPR/Cas9 technology. Based in Zug,..

Guardian Pharmacy Services, Inc. (GRDN): Analyst Ratings Suggest a Promising 6% Upside for Healthcare Investors

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) emerges as a compelling opportunity for investors looking to tap into the healthcare sector, especially within the niche of medical..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 5.41% Upside in a Dynamic Healthcare Sector

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector specializing in generic and specialty drug manufacturing, is drawing attention from investors with a..

HUTCHMED (China) Limited (HCM) Stock Analysis: Unpacking a 39% Potential Upside in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM) is a prominent player in the healthcare sector, specializing in the discovery and commercialization of targeted therapeutics and immunotherapies for cancer..

Omnicell, Inc. (OMCL) Investor Outlook: Examining a 45% Potential Upside Amid Healthcare Innovation

Omnicell, Inc. (OMCL) stands as a dynamic player in the healthcare sector, specifically in health information services. With a market capitalization of $1.82 billion, Omnicell is..

Zai Lab Limited (ZLAB): A Biotech Contender with 120% Upside Potential

Zai Lab Limited (NASDAQ: ZLAB), a leading player in the biotechnology sector, stands at a compelling crossroads for investors seeking growth opportunities in the healthcare industry...

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Play with 34.71% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial market potential. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds